Knockdown of the DJ-1 (PARK7) gene sensitizes pancreatic cancer to erlotinib inhibition

The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib, in combination with gemcitabine, has been shown to be a promising therapy in the treatment of pancreatic cancer. Our previous study showed that DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activat...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xiangyi, Sun, Yunwei, Fan, Rong, Sun, Jing, Zou, Douwu, Yuan, Yaozong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878983/
https://www.ncbi.nlm.nih.gov/pubmed/33614917
http://dx.doi.org/10.1016/j.omto.2021.01.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878983/
https://www.ncbi.nlm.nih.gov/pubmed/33614917
http://dx.doi.org/10.1016/j.omto.2021.01.013

Ejemplares similares